Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2011 Jan 13;19(7):1482–1491. doi: 10.1038/oby.2010.332

Figure 4.

Figure 4

Adjusted* Odds Ratios (95% Confidence Intervals) of Possessing 3 Inflammatory Markers in the Top Quartile associated with Body Size Phenotypes

Metabolic abnormalities considered were: 1.) systolic/diastolic blood pressure ≥130/85 mmHg or antihypertensive medication use, 2.) fasting triglycerides ≥1.7 mmol/L, 3.) HDL <1.3 mmol/L and 4.) fasting glucose ≥5.6 mmol/L or antidiabetic med use

*Adjusted for age, race-ethnicity, smoking, income, physical activity, education, hormone therapy use, NSAID use, baseline history of CVD, and stroke case-control status